Cognex earnings release, August 5, 2026
Cognex Reports Second Quarter 2026
Results
August 5, 2026 — NATICK, MA — Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the second quarter ended July 5, 2026.
Second-Quarter Financial and Operating Highlights
• Achieved record quarterly revenue of $291 million, driven by broad-based strength across most major end markets; second-quarter revenue increased 17% year over year, or 16% on a constant-currency basis.
• Operating margin was
29.4%; delivered an Adjusted EBITDA margin of
32.2%, up
1,150 basis points year over year, marking the eighth consecutive quarter of margin expansion.
• Net income per diluted share was $0.43; generated Adjusted diluted earnings per share of $0.45, up 80% year over year, representing the eighth consecutive quarter of growth.
• Issued full-year 2026 guidance anticipating strong double-digit revenue growth and significant year-over-year expansion in profitability.
• Announced the general availability of OneVision™, with hundreds of customers using the platform to accelerate configuration and deployment of AI-powered vision applications.
“Q2 was another strong quarter for Cognex and further evidence that our strategy is driving results,” said Matt Moschner, President and CEO. “We delivered exceptional performance, highlighted by record revenue, strong margin expansion, and significant earnings growth, which we believe reflects both a more favorable demand environment and focused execution across the business. We continue to make meaningful progress against our strategic objectives to extend our leadership in AI-enabled machine vision, deliver the leading customer experience in the industry, and double our customer base."
Mr. Moschner continued, "We believe that diversification is central to the next chapter of Cognex’s growth. We are focused on broadening our reach across customers, channels, adjacencies and end markets, while prioritizing the automation challenges where we expect our technology can create the most value. We believe this strategy will position Cognex to shape the future of AI-enabled machine vision and deliver more sustainable and profitable growth over time."
Dennis Fehr, CFO, added, “We believe that our Q2 performance underscores the strength of our profitable growth strategy and the strong leverage in our financial model. We are continuing to transform our operating model to drive higher productivity, support sustainable margin expansion, and strengthen our ability to scale efficiently over time. We believe that this disciplined approach will enable us to support Cognex’s long-term growth objectives while reinforcing our commitment to creating shareholder value."
Financial Performance Highlights for the Second Quarter
(Dollars in millions, except per share amounts)¹
Adjusted EBITDA and Adjusted EPS (Diluted) include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this news release.¹
• Revenue was
$291 million, compared with
$249 million in the second quarter of
2025, an increase of
17%. Excludin g the impact of foreign currency exchange (FX), revenue increased 16% compared to the prior year, driven by broad-based strength across most major end markets.
• Gross margin was
70.6% compared to
67.4% in the second quarter of
2025. Adjusted gross margin was
71.5% compared to
68.0% in the second quarter of
2025, an in crease of 350 basis points. The year-over-year increase was primarily driven by favorable mix and volume. Tariff refunds were not a material contributor to the strong gross margin performance.
• Operating expenses were
$120 million compared to
$124 million in the second quarter of
2025, a decrease of
3%. Adjusted operating expenses were
$119 million compared to
$123 million in the second quarter of
2025, a decrease of
3%. On a constant-currency basis, Adjusted operating expenses decreased 5% year over year, primarily driven by disciplined cost management.
• Operating income was $
86 million compared to
$43 million in the second quarter of
2025, an increase of
100%. Operating margin was
29.4% compared to
17.4% in the second quarter of
2025, an increase of
1,200 basis points. Adjusted operating margin was
30.7% compared to
18.7% in the second quarter of
2025, an increase of
1,200 basis points.
• Adjusted EBITDA was
$94 million compared to
$52 million in the second quarter of
2025, an increase of
81%. Adjusted EBITDA margin was
32.2% compared to
20.7% in the second quarter of
2025, an increase of 1,150 basis points. The year-over-year expansion was driven by revenue growth and favorable mix.
• Net income of
$73 million compared to
$41 million in the second quarter of
2025, an increase of
78%. Adjusted net income of
$76 million compared to
$43 million in the second quarter of
2025, an increase of
77%.
• Net income per diluted share was
$0.43 compared to
$0.24 in the second quarter of
2025, an increase of
79%. Adjusted diluted earnings per share were
$0.45 compared to
$0.25 in the second quarter of
2025, an increase of 80%.
Balance Sheet and Cash Flow Highlights
• As of July 5, 2026, Cognex’s financial position remained strong, with $755 million in cash and investments and no debt.
• During the second quarter, Cognex generated $69 million of cash from operating activities compared to $43 million in the second quarter of 2025, an increase of 60%.
• During the second quarter, Cognex generated Free Cash Flow (FCF) of $68 million compared to $40 million in the second quarter of 2025, an increase of 70%. Second quarter FCF conversion rate was 93% of net income and 89% of Adjusted net income. Trailing twelve-month FCF conversion rate was 153% of net income and 114% of Adjusted net income.
• ... (truncated)econd quarter.
Dividend
On August 5, 2026, Cognex's Board of Directors declared a quarterly cash dividend of $0.085 per share. The dividend is payable on September 3, 2026, to all shareholders of record at the close of business on August 20, 2026.²
Guidance
Cognex issued third-quarter and full-year 2026 guidance; details are summarized in the tables below.
Table 1: Third-Quarter 2026 Guidance
Table 2: Full-Year 2026 Guidance
* Excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the “CP”).
** At the midpoint of guidance.¹
Cognex has provided the forward-looking non-GAAP measures of adjusted EBITDA margin, and adjusted earnings per share (diluted), but cannot, without unreasonable effort, forecast such items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as reorganization charges, acquisition and integration charges, and amortization of acquisition-related intangible assets, all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of Cognex’s control. Additionally, these items are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results. Cognex believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, Cognex believes that the probable significance of such information is low. Information with respect to special items for certain historical periods is included in the section entitled “Reconciliation of Selected Items From GAAP to Non-GAAP”. In Q3 2025 the GAAP operating margin was 20.9% and GAAP earnings per share (diluted) were $0.10, and in full-year 2025, the GAAP operating margin was 16.3% and GAAP earnings per share (diluted) were $0.68.
Analyst Conference Call and Simultaneous Webcast
• Cognex will host a conference call on August 6, 2026, at 8:30 a.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 or (201) 389-0911 if outside the United States.
• A real-time audio broadcast of the conference call or an archived recording, together with a slide presentation, will be accessible on the Events & Presentations page of the Cognex Investor website: www.cognex.com/investor.³
Financial statements
Income Statement
Three-months ended — (Dollars in millions, except per share amounts)
| Three-months ended – July 05, 2026 | Three-months ended – June 29, 2025 | Y/Y Change | |
|---|---|---|---|
| Revenue | 291 | 249 | 17.0% |
| Operating Income | 86 | 43 | 100.0% |
| % of Revenue | 29.4% | 17.4% | +1,200 bps |
| Adjusted EBITDA1 | 94 | 52 | 81.0% |
| % of Revenue | 32.2% | 20.7% | +1,150 bps |
| Net Income per Diluted Share | 0.43 | 0.24 | 79.0% |
| Adjusted EPS (Diluted)1 | 0.45 | 0.25 | 80.0% |
Income Statement
Q3 2026 Guidance — Table 1: Third-Quarter 2026 Guidance (Dollars in millions, except per share amounts)
| Q3 2026 Guidance | Q3 2025 Results | Q3 2025 Results ex CP* | Y/Y Change** | Y/Y Change** ex CP* | |
|---|---|---|---|---|---|
| Revenue | $300 - $320 | 277 | 264 | 12.0% | 17.0% |
| Adj. EBITDA Margin1 | 32% - 35% | 24.9% | 22.1% | +860 bps | +1,140 bps |
| Adj. EPS (diluted)1 | $0.50 - $0.54 | 0.33 | 0.28 | 58.0% | 86.0% |
Income Statement
2026 Guidance — Table 2: Full-Year 2026 Guidance (Dollars in millions, except per share amounts)
| 2026 Guidance | 2025 Results | 2025 Results ex CP* | Y/Y Change** | Y/Y Change** ex CP* | |
|---|---|---|---|---|---|
| Revenue | $1,130 - $1,150 | 994 | 982 | 15.0% | 16.0% |
| Adj. EBITDA Margin1 | 29% - 31% | 21.5% | 20.7% | +850 bps | +930 bps |
| Adj. EPS (diluted)1 | $1.64 - $1.68 | 1.02 | 0.97 | 63.0% | 71.0% |
Income Statement
Three-months Ended — (In thousands, except per share amounts)
| Three-months Ended – July 5, 2026 | Three-months Ended – June 29, 2025 | Six-months Ended – July 5, 2026 | Six-months Ended – June 29, 2025 | ||
|---|---|---|---|---|---|
| Revenue | 291,263 | 249,093 | 559,700 | 465,129 | |
| Cost of revenue (1) | 85,490 | 81,217 | 162,988 | 152,930 | |
| Gross profit | 205,773 | 167,876 | 396,712 | 312,199 | |
| Percentage of revenue | 70.6 | 67.4 | 70.9 | 67.1 | |
| Research, development, and engineering expenses (1) | 32,391 | 33,102 | 69,416 | 67,829 | |
| Percentage of revenue | 11.1 | 13.3 | 12.4 | 14.6 | |
| Selling, general, and administrative expenses (1) | 87,865 | 91,341 | 181,906 | 174,845 | |
| Percentage of revenue | 30.2 | 36.7 | 32.5 | 37.6 | |
| Operating income | 85,517 | 43,433 | 145,390 | 69,525 | |
| Percentage of revenue | 29.4 | 17.4 | 26 | 14.9 | |
| Foreign currency gain (loss) | -862 | -1,503 | -2,207 | -3,956 | |
| Investment income | 5,091 | 4,040 | 9,927 | 8,030 | |
| Other income (expense) | -446 | 2,092 | -2,053 | 2,261 | |
| Income before income tax expense | 89,300 | 48,062 | 151,057 | 75,860 | |
| Income tax expense | 16,544 | 7,551 | 26,597 | 11,746 | |
| Net income | 72,756 | 40,511 | 124,460 | 64,114 | |
| Percentage of revenue | 25 | 16.3 | 22.2 | 13.8 | |
| Net income per weighted-average common and common-equivalent share: | Basic | 0.43 | 0.24 | 0.75 | 0.38 |
| Net income per weighted-average common and common-equivalent share: | Diluted | 0.43 | 0.24 | 0.74 | 0.38 |
| Weighted-average common and common-equivalent shares outstanding: | Basic | 167,346 | 167,886 | 166,921 | 168,568 |
| Weighted-average common and common-equivalent shares outstanding: | Diluted | 169,989 | 168,563 | 169,166 | 169,553 |
| Weighted-average common and common-equivalent shares outstanding: | Cash dividends per common share | 0.085 | 0.08 | 0.17 | 0.16 |
| (1) Amounts include stock-based compensation expense, as follows: | Cost of revenue | 592 | 537 | 1,517 | 1,205 |
| (1) Amounts include stock-based compensation expense, as follows: | Research, development, and engineering | 3,388 | 3,443 | 8,482 | 8,139 |
| (1) Amounts include stock-based compensation expense, as follows: | Selling, general, and administrative | 7,232 | 8,314 | 13,146 | 12,889 |
| (1) Amounts include stock-based compensation expense, as follows: | Total stock-based compensation expense | 11,212 | 12,294 | 23,145 | 22,233 |
Income Statement
Three-months Ended — (Unaudited)
| Three-months Ended – July 5, 2026 | Six-months Ended – June 29, 2025 | Six-months Ended – July 5, 2026 | June 29, 2025 | |
|---|---|---|---|---|
| Gross profit (GAAP) | 205,773 | 167,876 | 396,712 | 312,199 |
| Acquisition and integration costs | 218 | 211 | 434 | 453 |
| Amortization of acquisition-related intangible assets | 1,323 | 1,382 | 2,660 | 2,720 |
| Reorganization charges | 921 | 1,295 | 86 | |
| Adjusted gross profit | 208,235 | 169,469 | 401,101 | 315,458 |
| GAAP gross margin | 70.6 | 67.4 | 70.9 | 67.1 |
| Adjusted gross margin | 71.5 | 68 | 71.7 | 67.8 |
| Operating expense (GAAP) | 120,256 | 124,443 | 251,322 | 242,674 |
| Acquisition and integration costs | -15 | -259 | -30 | -797 |
| Amortization of acquisition-related intangible assets | -972 | -1,296 | -2,167 | -2,586 |
| Reorganization charges | -335 | -5,090 | -1,622 | |
| Adjusted operating expense | 118,934 | 122,888 | 244,035 | 237,669 |
| Operating income (GAAP) | 85,517 | 43,433 | 145,390 | 69,525 |
| Acquisition and integration costs | 233 | 470 | 464 | 1,250 |
| Amortization of acquisition-related intangible assets | 2,295 | 2,678 | 4,827 | 5,306 |
| Reorganization charges | 1,256 | 6,385 | 1,708 | |
| Adjusted operating income | 89,301 | 46,581 | 157,066 | 77,789 |
| GAAP operating margin | 29.4 | 17.4 | 26 | 14.9 |
| Adjusted operating margin | 30.7 | 18.7 | 28.1 | 16.7 |
| Depreciation (adjusted for amounts included in Acquisition and integration costs) | 4,358 | 5,095 | 8,830 | 10,178 |
| Adjusted EBITDA | 93,659 | 51,676 | 165,896 | 87,967 |
| Adjusted EBITDA margin | 32.2 | 20.7 | 29.6 | 18.9 |
| Net income (GAAP) | 72,756 | 40,511 | 124,460 | 64,114 |
| Acquisition and integration costs | 233 | 470 | 464 | 1,250 |
| Amortization of acquisition-related intangible assets | 2,295 | 2,678 | 4,827 | 5,306 |
| Reorganization charges | 1,256 | 6,385 | 1,708 | |
| Loss on sale of business | 1,539 | |||
| Discrete tax (benefit) expense | 450 | -211 | -729 | -518 |
| Tax impact of reconciling items | -1,102 | -891 | -3,740 | -2,256 |
| Adjusted net income | 75,888 | 42,557 | 133,206 | 69,604 |
| Earnings per share of common stock, diluted (GAAP) | 0.43 | 0.24 | 0.74 | 0.38 |
| Acquisition and integration costs | 0 | 0 | 0 | 0.01 |
| Amortization of acquisition-related intangible assets | 0.01 | 0.02 | 0.03 | 0.03 |
| Reorganization charges | 0.01 | 0.04 | 0.01 | |
| Loss on sale of business | 0.01 | |||
| Discrete tax (benefit) expense | 0 | 0 | 0 | 0 |
Balance Sheet
July 5, 2026 — (in thousands, except per share amounts)
| July 5, 2026 – (unaudited) | December 31, 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 302,521 | 262,925 |
| Current assets: | Current investments | 101,849 | 74,037 |
| Current assets: | Accounts receivable, net of allowance for credit losses of $726 and $728 in 2026 and 2025, respectively | 216,232 | 146,713 |
| Current assets: | Unbilled revenue | 12,684 | 16,980 |
| Current assets: | Inventories | 142,839 | 137,889 |
| Current assets: | Prepaid expenses and other current assets | 73,755 | 58,702 |
| Current assets: | Total current assets | 849,880 | 697,246 |
| Current assets: | Non-current investments | 350,643 | 305,339 |
| Current assets: | Property, plant, and equipment, net | 81,452 | 86,015 |
| Current assets: | Operating lease assets | 68,543 | 72,310 |
| Current assets: | Goodwill | 381,385 | 386,279 |
| Current assets: | Intangible assets, net | 64,464 | 81,100 |
| Current assets: | Deferred income taxes | 377,830 | 383,272 |
| Current assets: | Other assets | 4,453 | 4,994 |
| Current assets: | Total assets | 2,178,650 | 2,016,555 |
| Current liabilities: | Accounts payable | 65,060 | 50,203 |
| Current liabilities: | Accrued expenses | 80,586 | 91,397 |
| Current liabilities: | Accrued income taxes | 9,126 | 9,141 |
| Current liabilities: | Deferred revenue and customer deposits | 48,978 | 21,094 |
| Current liabilities: | Operating lease liabilities | 12,281 | 11,716 |
| Current liabilities: | Total current liabilities | 216,031 | 183,551 |
| Current liabilities: | Non-current operating lease liabilities | 60,196 | 64,870 |
| Current liabilities: | Deferred income taxes | 248,888 | 250,512 |
| Current liabilities: | Reserve for income taxes | 21,963 | 24,269 |
| Current liabilities: | Other liabilities | 2,017 | 1,452 |
| Current liabilities: | Total liabilities | 549,095 | 524,654 |
| Shareholders’ equity: | Common stock, $.002 par value – Authorized: 300,000 shares in 2026 and 2025, respectively; issued and outstanding: 168,217 and 166,997 shares in 2026 and 2025, respectively | 336 | 334 |
| Shareholders’ equity: | Additional paid-in capital | 1,294,544 | 1,138,708 |
| Shareholders’ equity: | Retained earnings | 397,135 | 406,355 |
| Shareholders’ equity: | Accumulated other comprehensive loss, net of tax | -62,460 | -53,496 |
| Shareholders’ equity: | Total shareholders’ equity | 1,629,555 | 1,491,901 |
| Shareholders’ equity: | Total liabilities and shareholders' equity | 2,178,650 | 2,016,555 |
Full release
Forward-Looking Statements
Certain statements made in this report, as well as oral statements made by Cognex Corporation ("Cognex", "we", "us", "our", or the "Company") from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Readers can identify these forward-looking statements by our use of the words "expects," "anticipates," "estimates," "potential," "believes," "projects," "intends," "plans," "aims," "will," "may," "shall," "could," "should," "opportunity," "goal," "objective," "target," "milestone" and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, financial targets, milestones and related timing expectations, the impacts of our strategic portfolio review, the impact of tariffs, customer demand and order rates and timing of related revenue, future product or revenue mix, research and development activities, sales and marketing activities including our salesforce transformation, new product offerings, innovation and product development activities, customer acceptance of our products, commercial partnerships, capital expenditures, cost management activities including expected annualized operating expense reductions, investments, liquidity, dividends and stock repurchases, strategic and growth plans and opportunities, financial and operating models, acquisitions, and estimated tax benefits and expenses, changes in tax legislation, and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the technological obsolescence of current products, the inability to develop new products, and the inability to achieve growth through expanding and adjacent markets; (2) the impact of competitive pressures; (3) the inability to attract and retain skilled employees and effectively plan for succession, while maintaining our unique corporate culture; (4) the failure to properly manage the distribution of products and services; (5) economic, political, and other risks associated with international sales and operations, including the impact of trade disputes, the imposition of tariffs, the economic climate in China, and the wars and conflicts involving Iran, Ukraine, and Israel and those that may arise in the future in the geographies where we conduct business; (6) the challenges in integrating and achieving expected results from acquired businesses; (7) uncertainty surrounding our future capital needs; (8) the inability to effectively scale our operations and salesforce to support a significantly expanded customer base in an increasing number of geographies; (9) information security breaches and other cybersecurity threats; (10) the failure to comply with laws or regulations relating to data privacy, data protection, artificial intelligence, or other automated technologies; (11) the inability to protect our proprietary technology and intellectual property; (12) the inability to manage direct and indirect disruptions to our supply chain, which could cause delays in obtaining components for our products at reasonable prices; (13) the failure to manufacture and deliver products in a timely manner; (14) the inability to obtain, or the delay in obtaining, components for our products at reasonable prices, including memory chips; (15) the inability to design and manufacture high-quality products; (16) the loss of, or curtailment of purchases by, large customers in the logistics, consumer electronics, or automotive end markets; (17) challenges in accurately forecasting our financial results due to seasonal and cyclical variations in customer purchasing patterns and economic and market volatility; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities, increases and fluctuations in our effective tax rate, and other tax matters; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) unfavorable global economic conditions, including, without limitation, increases in interest rates, elevated inflation rates, and recession risks; (22) business disruptions from natural or man-made disasters, public health crises, or other events outside our control; (23) stock price volatility; (24) our involvement in time-consuming and costly litigation or activist shareholder activities; and (25) the failure to effectively transform our operating model, manage our expenses, and achieve expected cost reductions. The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I - Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Annual Report"), as updated by Part II - Item 1A of our Quarterly Reports on Form 10-Q as filed with the SEC. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made.⁴